BioReperia is dedicated to the task of improving the lives of millions of people around the world suffering from cancer and bone diseases. One important step that must be taken in order to procure high quality treatments is to lower the cost and time of drug development. With our novel analysis methods, we are able to test drug candidates faster and cheaper, while still maintaining high precision.

Our methods sprung from the research at Linköping University and we maintain a strong link to the academic community. This allows us to expand our business and always be at the frontier of our expertise and also to be able to anticipate the development of osteological and oncological research.